Tiger BufordYour Orthopedic Industry Expert (free today)

Introduction of Nanochon and their Chondrograft technology for cartilage repair on BoneChat short 52

16 Nov 2024 · 1 min

Watch on YouTube

0:40

In this BoneChat short, the co‑founder and CEO of Nanocon explains the company’s focus on developing the ChondroGraft implant, a novel solution for cartilage repair and regeneration. He describes how cartilage naturally loses durability over time, leading to lesions, and notes the current lack of robust treatments for such defects. The technology is aimed at younger, active patients who have cartilage damage requiring surgery but are not yet candidates for total knee replacement.

Chapters

I can't wait for somebody to crack the code on cartilage. I'm the co-founder and CEO of Nanocon. As Tiger said, we're an early-stage company developing the ChondroGraft implant to treat one of the biggest problems in orthopedics today, and that is cartilage repair and cartilage regeneration. You know, cartilage over time loses its ability to stay durable and wears away, and you eventually get the formation of lesions or potholes in the surface. And we know that there is not a good robust treatment for these defects today. So we want to focus on these, these younger and more active patients who do have cartilage damage and need a surgery but are not yet a candidate for knee replacements.